Paper8690804
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
Vetvicka V and 2 others. J Clin Invest, 1996. Cited by 298 papers, by iCite.
Cite this record
ConductScience Library. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. Papers, record 8690804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8690804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Glucans | Major topic |
| Killer Cells, Natural | Major topic |
| Macrophage-1 Antigen | Major topic |
| Neutrophils | Major topic |
| Receptors, Mitogen | Major topic |
| Animals | |
| Cell Membrane | |
| Hemolysis | |
| Humans | |
| Inflammation | |
| Mice | |
| Neutrophil Activation | |
| Opsonin Proteins | |
| Signal Transduction | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 A127771-15 | PHS HHS | United States | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8690779 | The continuing saga of complement receptor type 3 (CR3) | https://conductscience.org/library/papers/8690779 |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3729450 | [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3729450 | PubMed |
| 2 | 1623902 | In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1623902 | PubMed |
| 3 | 458151 | Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activities. | J Immunol | 1979 | https://conductscience.org/library/papers/458151 | PubMed |
| 4 | 1371129 | Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. | J Immunol | 1992 | https://conductscience.org/library/papers/1371129 | PubMed |
| 5 | 2479549 | Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. | EMBO J | 1989 | https://conductscience.org/library/papers/2479549 | PubMed |
| 6 | 2579899 | Antigenic relationship between the alpha-chain of C3, a leucocyte-surface antigen involved in the activation of phagocytic cells, and a 50,000 MW B-cell antigen. | Immunology | 1985 | https://conductscience.org/library/papers/2579899 | PubMed |
| 7 | 6650280 | Clinical efficacy of lentinan on neoplastic diseases. | Adv Exp Med Biol | 1983 | https://conductscience.org/library/papers/6650280 | PubMed |
| 8 | 1980339 | Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. | Mol Immunol | 1990 | https://conductscience.org/library/papers/1980339 | PubMed |
| 9 | 1524956 | Evaluation of basic procedures for adoptive immunotherapy for gastric cancer. | Biotherapy | 1992 | https://conductscience.org/library/papers/1524956 | PubMed |
| 10 | 7451976 | Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. | J Immunol | 1981 | https://conductscience.org/library/papers/7451976 | PubMed |
| 11 | 8057364 | Crystallization and preliminary X-ray diffraction studies on cytosolic (class 1) aldehyde dehydrogenase from sheep liver. | J Mol Biol | 1994 | https://conductscience.org/library/papers/8057364 | PubMed |
| 12 | 8452390 | [A case of breast cancer with thrombosis during treatment of lung metastasis]. | Gan To Kagaku Ryoho | 1993 | https://conductscience.org/library/papers/8452390 | PubMed |
| 13 | 1596373 | Complement receptors. | Curr Opin Immunol | 1992 | https://conductscience.org/library/papers/1596373 | PubMed |
| 14 | 2936810 | Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes. | J Immunol | 1986 | https://conductscience.org/library/papers/2936810 | PubMed |
| 15 | 2522826 | Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments. | Cell Immunol | 1989 | https://conductscience.org/library/papers/2522826 | PubMed |
| 16 | 3121179 | Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. | Cancer Detect Prev Suppl | 1987 | https://conductscience.org/library/papers/3121179 | PubMed |
| 17 | 1902259 | Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. | J Pharmacol Exp Ther | 1991 | https://conductscience.org/library/papers/1902259 | PubMed |
| 18 | 7768958 | Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burst. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7768958 | PubMed |
| 19 | 1426662 | Recent progress in immunopharmacology and therapeutic effects of polysaccharides. | Dev Biol Stand | 1992 | https://conductscience.org/library/papers/1426662 | PubMed |
| 20 | 8100571 | CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. | J Clin Immunol | 1993 | https://conductscience.org/library/papers/8100571 | PubMed |
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 298 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42564158 | Natural polysaccharides as immunometabolic modulators in metabolic diseases: mechanisms and translational challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42564158 | PubMed |
| 42512356 | β-Glucans, Triterpenes and Nucleoside Analogs of Edible and Medicinal Mushrooms as Complementary Treatment in Diabetes and Cancer-A Review of Evidence from Clinical Trials. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512356 | PubMed |
| 42022264 | Immune Responses to Pneumocystis in HIV-Infected and Non-HIV Immunocompromised Hosts. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42022264 | PubMed |
| 41268444 | Recent advances in Bletilla striata polysaccharide research: extraction methodologies, structural elucidation, pharmacological mechanisms, structure-activity relationships, and therapeutic delivery applications. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41268444 | PubMed |
| 41000281 | Breeding of Fukumi Fiber, a new six-rowed waxy hull-less barley cultivar containing high levels of β-glucan with a proanthocyanidin-free gene. | Breed Sci | 2025 | https://conductscience.org/library/papers/41000281 | PubMed |
| 39596318 | Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596318 | PubMed |
| 38806144 | Complement receptor 3-dependent engagement by Candida glabrata β-glucan modulates dendritic cells to induce regulatory T-cell expansion. | Open Biol | 2024 | https://conductscience.org/library/papers/38806144 | PubMed |
| 38724513 | Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans. | Nat Commun | 2024 | https://conductscience.org/library/papers/38724513 | PubMed |
| 38201110 | Screening and Characteristics Analysis of Polysaccharides from Orah Mandarin (Citrus reticulata cv. Orah). | Foods | 2023 | https://conductscience.org/library/papers/38201110 | PubMed |
| 37975017 | Receptor basis of biological activity of polysaccharides. | Biophys Rev | 2023 | https://conductscience.org/library/papers/37975017 | PubMed |
| 36374100 | Mucosal Infection with Unmasked Candida albicans Cells Impacts Disease Progression in a Host Niche-Specific Manner. | Infect Immun | 2022 | https://conductscience.org/library/papers/36374100 | PubMed |
| 36190144 | The role of neutrophils in trained immunity. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36190144 | PubMed |
| 36053290 | PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36053290 | PubMed |
| 35760297 | Exopolysaccharide from the yeast Papiliotrema terrestris PT22AV for skin wound healing. | J Adv Res | 2023 | https://conductscience.org/library/papers/35760297 | PubMed |
| 35328577 | From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328577 | PubMed |
| 35288363 | CD11b agonists offer a novel approach for treating lupus nephritis. | Transl Res | 2022 | https://conductscience.org/library/papers/35288363 | PubMed |
| 34867977 | Complement-Mediated Differential Immune Response of Human Macrophages to Sporothrix Species Through Interaction With Their Cell Wall Peptidorhamnomannans. | Front Immunol | 2021 | https://conductscience.org/library/papers/34867977 | PubMed |
| 34065946 | β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy. | Nutrients | 2021 | https://conductscience.org/library/papers/34065946 | PubMed |
| 33995387 | The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology. | Front Immunol | 2021 | https://conductscience.org/library/papers/33995387 | PubMed |
| 33946381 | Insights on the Functional Role of Beta-Glucans in Fungal Immunity Using Receptor-Deficient Mouse Models. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33946381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8690804
GET https://conductscience.org/api/papers/v1/8690804/references?page=2